Pay in 4 interest-free payments of $7.09 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
406,407,408 A phase 2 RCT demonstrated that berberine ursodeoxycholate significantly reduced liver fat content, improved glycemic control, lowered liver enzyme levels, and promoted weight loss in T2D patients with presumed NASH
Patients Taking Medication Dosage Into Their Own Hands According to the LA Times, some patients, with or without the help of doctors, are experimenting with microdosing weight loss drugsusing smaller-than-recommended amountsin order to stretch limited supplies, reduce costs, and even potentially curb side effects. 91% of surveyed healthcare providers reported they are somewhat to very concerned about patients independently adjusting their prescribed medication doses
Description Chemical Information of BPC-157 Molecular Formula: CHNO CAS Number: 137525-51-0 Molecular Weight: 1419.54 g/mol Sequence: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val Storage and Handling of BPC-157 Store sealed at recommended laboratory freezer temperatures
No large-scale phase 3 trials have been completed
